Website
View Website
- Soy Protein Isolate Affects Blood and Brain Biomarker Expression in a Mouse Model of Fragile X
- Soy-based purified ingredient diet affects mouse gut permeability and the microbiome in fragile X mice
- Prophylactic or Poison: The Folic Acid Debate
- Bibliometric Analysis and a Call for Increased Rigor in Citing Scientific Literature: Folic Acid Fortification and Neural Tube Defect Risk as an Example
- Adult Inception of Ketogenic Diet Therapy Increases Sleep during the Dark Cycle in C57BL/6J Wild Type and Fragile X Mice
- Effects of Soy Protein Isolate on Fragile X Phenotypes in Mice
- On-Tissue Spatial Proteomics Integrating MALDI-MS Imaging with Shotgun Proteomics Reveals Soy Consumption-Induced Protein Changes in a Fragile X Syndrome Mouse Model
- Toward an understanding of the role of the exposome on fragile X phenotypes
- Ketogenic Diet Affects Sleep Architecture in C57BL/6J Wild Type and Fragile X Mice
- Diet in treatment of autism spectrum disorders
Dr. Westmark’s basic and translational science research laboratory studies pharmaceutical and dietary interventions for the treatment of fragile X syndrome, autism and Alzheimer’s disease with a focus on the synaptic function of amyloid beta protein precursor (APP) and amyloid-beta. She employs mouse models of neurological disorders and human survey data to correlate promising treatments with improved behavioral (seizure, cognitive, hyperactivity/sleep) and biomarker data.